The epidermis is a stratified tissue composed of different keratinocyte layers that create a barrier protecting the body from external influences, pathogens, and dehydration. The barrier function is mainly achieved by its outermost layer, the stratum corneum. To create a mouse model to study pathophysiological processes in the outermost layers of the epidermis in vivo and in vitro we prepared a construct containing red fluorescent td-Tomato reporter sequence under the control of involucrin promoter and its first intron. Transgenic mice were generated by pronuclear injection and the expression and regulation of the transgene was determined by in vivo imaging and fluorescent microscopy. The promoter targeted the transgene efficiently and specifically into the outermost epidermal layers although weak expression was also found in epithelia of tongue and bladder. The regulation of expression in the epidermis, i.e. fluorescence intensity of the reporter, could be easily followed during wound healing and dermatitis. Thus, these transgenic mice carrying the tdTomato reporter could be used as a valuable tool to study impact of various genes dysregulating the epidermal barrier and to follow effects of therapeutic agents for treatment of skin diseases in vivo.

Department of Transgenic Models of Diseases Institute of Molecular Genetics of the ASCR v v i Vídeňská 1083 14220 Prague 4 Czech Republic

Zobrazit více v PubMed

Urol Res. 1989;17(5):279-83 PubMed

J Cell Sci. 1992 Dec;103 ( Pt 4):925-30 PubMed

Development. 2002 Apr;129(7):1775-84 PubMed

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7629-34 PubMed

Arch Dermatol Res. 1991;283(4):246-50 PubMed

EMBO J. 1993 Jul;12(7):2635-43 PubMed

Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10270-4 PubMed

Oral Surg Oral Med Oral Pathol. 1986 Aug;62(2):155-63 PubMed

Cell. 1979 Nov;18(3):681-94 PubMed

J Pathol. 1985 Apr;145(4):329-40 PubMed

Cell. 1981 Sep;25(3):617-25 PubMed

J Cell Biol. 1987 Jul;105(1):427-40 PubMed

J Invest Dermatol. 2005 Aug;125(2):183-200 PubMed

J Invest Dermatol. 2010 Feb;130(2):388-97 PubMed

Cell. 1986 Aug 15;46(4):583-9 PubMed

Mol Carcinog. 1999 Jun;25(2):122-31 PubMed

Agents Actions. 1986 Dec;19(5-6):371-3 PubMed

Mol Biol Cell. 1999 Dec;10(12):4247-61 PubMed

Exp Dermatol. 1998 Feb;7(1):1-10 PubMed

Cell. 1977 Jun;11(2):417-22 PubMed

Gene Ther. 2002 Oct;9(19):1278-85 PubMed

J Invest Dermatol. 1995 Mar;104(3):391-5 PubMed

Nat Rev Mol Cell Biol. 2005 Apr;6(4):328-40 PubMed

J Virol. 1997 Dec;71(12):9163-9 PubMed

Exp Mol Med. 1999 Mar 31;31(1):5-19 PubMed

J Cell Biol. 1981 Sep;90(3):732-7 PubMed

Mol Cell Biol. 2002 Aug;22(16):5846-58 PubMed

Nat Biotechnol. 2004 Dec;22(12):1567-72 PubMed

Differentiation. 1992 Jan;49(1):39-46 PubMed

Cell. 1990 Jun 15;61(6):1103-12 PubMed

Bioessays. 2002 Sep;24(9):789-800 PubMed

Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):219-26 PubMed

KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype